BG
Bellevue Group’s Supernus Pharmaceuticals SUPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,100
| Closed | -$437K | – | 177 |
|
|
2023
Q4 | $437K | Sell |
15,100
-565,500
| -97% | -$16.4M | 0.01% | 136 |
|
|
2023
Q3 | $16M | Sell |
580,600
-69,656
| -11% | -$1.92M | 0.26% | 77 |
|
|
2023
Q2 | $19.5M | Buy |
650,256
+527,375
| +429% | +$15.9M | 0.28% | 80 |
|
|
2023
Q1 | $4.45M | Buy |
122,881
+11,835
| +11% | +$429K | 0.06% | 107 |
|
|
2022
Q4 | $3.96M | Sell |
111,046
-8,232
| -7% | -$294K | 0.05% | 114 |
|
|
2022
Q3 | $4.04M | Buy |
119,278
+36,878
| +45% | +$1.25M | 0.06% | 112 |
|
|
2022
Q2 | $2.38M | Buy |
82,400
+23,400
| +40% | +$677K | 0.03% | 125 |
|
|
2022
Q1 | $1.91M | Buy |
+59,000
| New | +$1.91M | 0.02% | 136 |
|
|
2020
Q2 | – | Sell |
-552,800
| Closed | -$9.95M | – | 223 |
|
|
2020
Q1 | $9.95M | Sell |
552,800
-22,800
| -4% | -$410K | 0.19% | 88 |
|
|
2019
Q4 | $13.7M | Buy |
575,600
+159,000
| +38% | +$3.77M | 0.22% | 78 |
|
|
2019
Q3 | $11.4M | Sell |
416,600
-50,400
| -11% | -$1.38M | 0.21% | 80 |
|
|
2019
Q2 | $15.5M | Buy |
467,000
+176,000
| +60% | +$5.82M | 0.26% | 66 |
|
|
2019
Q1 | $10.2M | Sell |
291,000
-54,100
| -16% | -$1.9M | 0.56% | 53 |
|
|
2018
Q4 | $11.5M | Sell |
345,100
-41,400
| -11% | -$1.38M | 0.75% | 40 |
|
|
2018
Q3 | $19.5M | Buy |
386,500
+59,900
| +18% | +$3.02M | 1.23% | 24 |
|
|
2018
Q2 | $19.5M | Buy |
326,600
+37,800
| +13% | +$2.26M | 1.67% | 21 |
|
|
2018
Q1 | $13.2M | Buy |
288,800
+48,400
| +20% | +$2.22M | 1.31% | 27 |
|
|
2017
Q4 | $9.58M | Buy |
+240,400
| New | +$9.58M | 1% | 40 |
|
|
2016
Q3 | – | Sell |
-164,000
| Closed | -$3.34M | – | 124 |
|
|
2016
Q2 | $3.34M | Sell |
164,000
-277,000
| -63% | -$5.64M | 0.63% | 51 |
|
|
2016
Q1 | $6.73M | Buy |
+441,000
| New | +$6.73M | 1.22% | 24 |
|